pembrolizumab FDA approval date

The FDA approved pembrolizumab (KEYTRUDA®) on 4 Sep 2014.

FDA approval date
4 Sep 2014

Drug identity checked against registry records

Also recorded as KEYTRUDA®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2014-09-04DaypembrolizumabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA125514", "applicant_as_listed_by_fda": "MERCK SHARP DOHME", "brand_names": ["KEYTRUDA"], "active_ingredients": ["PEMBROLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140904", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026